Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Synonyms :
Class :
Individuals diagnosed with advanced solid malignancies underwent treatment with increasing doses of this medication via intravenous (i.v.) infusion lasting 60 minutes
The drug has been demonstrated to be safely administered at a weekly intravenous dose of 15 mg/kg
Dose Adjustments
Limited data is available
combining volociximab with amivantamab may increase the chances of adverse effects
combining volociximab with anifrolumab may increase the chances of adverse effects
combining abciximab with volociximab may heighten the chances of adverse effects
combining volociximab with aducanumab may increase the chances of adverse effects
the chances of adverse effects can be raised when alemtuzumab is combined with volociximab
the risk or extent of jaw osteonecrosis and anti-angiogenesis can be raised when volociximab is combined with alendronic acid
combining volociximab with alirocumab may increase the chances of adverse effects
the risk or extent of methemoglobinemia can be raised when volociximab is combined with ambroxol
combining volociximab with ansuvimab may increase the chances of adverse effects